Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Andersen

Showing results (41-50 of 1,461) with videos related to

Pageof 147
Sort By:
European Journal of Pharmacology|August 3, 1989
The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of actionP H Andersen
Ugeskrift for Laeger|April 30, 1973
[Medicinal charcoal in the treatment of poisoning. Treatment of experimental barbiturate poisoning in pigs]H H Andersen
Ugeskrift for Laeger|June 18, 1973
[Drug problems and the Common Market. Personal views]A H Andersen
Sygeplejersken|November 2, 1988
[Why can't I get leave of absence when my wife will give birth?]S H Andersen
Ultrasonic Imaging|October 1, 1990
A ray tracing approach to restoration and resolution enhancement in experimental ultrasound tomographyA H Andersen
Acta Pharmacologica Et Toxicologica|October 29, 2010
Experimental studies on the pharmacology of activated charcoal; adsorption power of charcoal in aqueous solutionsA H ANDERSEN
European Journal of Pharmacology|January 27, 1988
Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brainP H Andersen
Current Opinion in Molecular Therapeutics|July 22, 2004
Technology evaluation: rh lactoferrin, AgennixJeanette H Andersen
Ugeskrift for Laeger|October 20, 1975
[European Economic Community rulings on drugs. Decisions on directives, norms and directions and the decision of the Council about a diminishing drug selection]A H Andersen
Ugeskrift for Laeger|October 27, 1975
[Editorial: Death following dextropropoxyphene intake]A H Andersen
Pageof 147

Showing results (41-50 of 1,461) with videos related to

Sort By:
Pageof 147
European Journal of Pharmacology|August 3, 1989
The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of actionP H Andersen
Ugeskrift for Laeger|April 30, 1973
[Medicinal charcoal in the treatment of poisoning. Treatment of experimental barbiturate poisoning in pigs]H H Andersen
Ugeskrift for Laeger|June 18, 1973
[Drug problems and the Common Market. Personal views]A H Andersen
Sygeplejersken|November 2, 1988
[Why can't I get leave of absence when my wife will give birth?]S H Andersen
Ultrasonic Imaging|October 1, 1990
A ray tracing approach to restoration and resolution enhancement in experimental ultrasound tomographyA H Andersen
Acta Pharmacologica Et Toxicologica|October 29, 2010
Experimental studies on the pharmacology of activated charcoal; adsorption power of charcoal in aqueous solutionsA H ANDERSEN
European Journal of Pharmacology|January 27, 1988
Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brainP H Andersen
Current Opinion in Molecular Therapeutics|July 22, 2004
Technology evaluation: rh lactoferrin, AgennixJeanette H Andersen
Ugeskrift for Laeger|October 20, 1975
[European Economic Community rulings on drugs. Decisions on directives, norms and directions and the decision of the Council about a diminishing drug selection]A H Andersen
Ugeskrift for Laeger|October 27, 1975
[Editorial: Death following dextropropoxyphene intake]A H Andersen
Pageof 147